Skip to main content

Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation

Clinical Research in Cardiology volume 106, pages 183–191 (2017)Cite this article

Abstract

Background

Despite the completion of more than 60,000 transcutaneous aortic valve implantations (TAVI) per year and an approximately 10–15 % incidence of vascular access site complications (VAC), there is a paucity of data on the efficacy and safety of percutaneous VAC treatment.

Hypothesis

Percutaneous endovascular treatment will be an effective treatment of VAC and associated with a low rate of surgical repair. Despite stent placement in proximity to the hip joint, endovascular treatment will be only rarely associated with disabling symptoms or complications.

Methods

We conducted a retrospective database analysis including 355 patients who underwent TAVI from January 2011 to October 2015. To facilitate the detection of secondary complications of interventional VAC repair, we conducted structured telephone interviews with a focus on new diagnoses or symptoms of peripheral artery disease.

Results

Only four patients (1.1 %) required surgical treatment for VAC. Percutaneous balloon angioplasty (PTA) or stent implantation was required for VAC in 44 patients (12.4 %). The technical success rate of percutaneous VAC treatment was 93 %. Four patients died within 30 days of VAC treatment, but only one fatality was directly attributable to VAC. Post procedure mean hospital stay was numerically prolonged by 2.4 days in the VAC treatment group (P = 0.06). During a median follow-up of 385 days (range 89–909 days) none of the patients were diagnosed with a late VAC or reported a new diagnosis or symptoms of perfusion deficit or peripheral artery disease.

Conclusion

Percutaneous treatment of VAC during TAVI is safe and effectively helps to minimize the need for surgery in the vast majority of VAC. During short- and mid-term follow-up, percutaneous VAC management is associated with low complication rates and good clinical outcomes.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Babalik E, Gulbaran M, Gurmen T et al (2003) Fracture of popliteal artery stents. Circ J 67:643–645

    Article  PubMed  Google Scholar 

  2. Bax JJ, Delgado V, Bapat V et al (2014) Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J 35:2627–2638

    Article  PubMed  Google Scholar 

  3. Borz B, Durand E, Godin M et al (2013) Incidence, predictors and impact of bleeding after transcatheter aortic valve implantation using the balloon-expandable Edwards prosthesis. Heart 99:860–865

    Article  PubMed  Google Scholar 

  4. Calligaro KD, Balraj P, Moudgill N et al (2013) Results of polytetrafluoroethylene-covered nitinol stents crossing the inguinal ligament. J Vasc Surg 57:421–426

    Article  PubMed  Google Scholar 

  5. De Backer O, Arnous S, Sandholt B et al (2015) Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation. Am J Cardiol 115:1123–1129

    Article  PubMed  Google Scholar 

  6. Frerker C, Schewel D, Kuck KH et al (2013) Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 81:592–602

    Article  PubMed  Google Scholar 

  7. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Eng J Med 374(17):1609–1620

    CAS  Article  Google Scholar 

  8. Puri R, Iung B, Cohen DJ et al (2016) TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J 37(28):2217–2225

    Article  PubMed  Google Scholar 

  9. Sharp AS, Michev I, Maisano F et al (2010) A new technique for vascular access management in transcatheter aortic valve implantation. Cathete Cardiovasc Interv 75:784–793

    Article  Google Scholar 

  10. Thiney PO, Millon A, Boudjelit T et al (2015) Angioplasty of the common femoral artery and its bifurcation. Ann Vasc Surg 29:960–967

    Article  PubMed  Google Scholar 

  11. Toggweiler S, Leipsic J, Binder RK et al (2013) Management of vascular access in transcatheter aortic valve replacement: part 2: vascular complications. JACC 6:767–776

    PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Cardiology and Pulmonology, University Medical Center Göttingen, Georg-August-University, Robert-Koch-Straße 40, 37075, Göttingen, Germany

    Tim Seidler, Mark Hünlich, Miriam Puls, Gerd Hasenfuß & Claudius Jacobshagen

Authors
  1. Tim Seidler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Hünlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miriam Puls
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gerd Hasenfuß
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Claudius Jacobshagen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tim Seidler.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Seidler, T., Hünlich, M., Puls, M. et al. Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol 106, 183–191 (2017). https://doi.org/10.1007/s00392-016-1038-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-016-1038-1

Keywords

  • Transcatheter aortic valve implantation
  • Vascular access site complications
  • Self-expanding vascular stent
  • Peripheral vascular intervention